Alibaba Health Information Technology Limited (HKG:0241)
Hong Kong
· Delayed Price · Currency is HKD | Market Cap | 71.61B |
| Revenue (ttm) | 36.09B |
| Net Income (ttm) | 2.11B |
| Shares Out | 16.16B |
| EPS (ttm) | 0.13 |
| PE Ratio | 33.99 |
| Forward PE | 25.10 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 67,118,251 |
| Average Volume | 80,511,945 |
| Open | 4.510 |
| Previous Close | 4.550 |
| Day's Range | 4.400 - 4.530 |
| 52-Week Range | 4.120 - 7.910 |
| Beta | 1.69 |
| RSI | 36.61 |
| Earnings Date | May 20, 2026 |
About HKG:0241
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, medical c... [Read more]
Financial Performance
In fiscal year 2025, HKG:0241's revenue was 30.60 billion, an increase of 13.22% compared to the previous year's 27.03 billion. Earnings were 1.43 billion, an increase of 62.14%.
Financial numbers in CNY Financial StatementsNews
Apps in Beijing's crosshairs as crackdown heats up
U.S.-traded shares of several China-based tech-related firms, including Alibaba Holding, Tencent Music Entertainment Group and iQiyi, slid on Thursday in the wake of Beijing's findings that 43 apps il...
China's digital health care start-ups get a boost from the coronavirus, Beijing and investors
The coronavirus pandemic is proving to be the accelerator that China's health care technology start-ups needed.
Alibaba Health raises $1.3 billion in Hong Kong's biggest secondary share sale in 5 years
Chinese healthcare services firm Alibaba Health Information Technology has raised nearly $1.3 billion in Hong Kong's largest follow-on share sale in five years, according a statement from the company ...